These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25948698)

  • 1. Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes.
    Powers C; Gabriel MH; Encinosa W; Mostashari F; Bynum J
    J Am Med Inform Assoc; 2015 Sep; 22(5):1094-8. PubMed ID: 25948698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-Prescribing and Adverse Drug Events: An Observational Study of the Medicare Part D Population With Diabetes.
    Gabriel MH; Powers C; Encinosa W; Bynum JP
    Med Care; 2017 May; 55(5):456-462. PubMed ID: 28060051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meaningful use of health information technology and declines in in-hospital adverse drug events.
    Furukawa MF; Spector WD; Rhona Limcangco M; Encinosa WE
    J Am Med Inform Assoc; 2017 Jul; 24(4):729-736. PubMed ID: 28339642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
    Eguale T; Buckeridge DL; Verma A; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    JAMA Intern Med; 2016 Jan; 176(1):55-63. PubMed ID: 26523731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?
    Green JL; Hawley JN; Rask KJ
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):31-9. PubMed ID: 17608245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of adverse drug events in e-prescribing and administrative health data: a validation study.
    Habib B; Tamblyn R; Girard N; Eguale T; Huang A
    BMC Health Serv Res; 2021 Apr; 21(1):376. PubMed ID: 33892716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
    Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
    Trials; 2015 Jan; 16():2. PubMed ID: 25572800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
    Stuart B; Simoni-Wastila L; Yin X; Davidoff A; Zuckerman IH; Doshi J
    Med Care; 2011 May; 49(5):511-5. PubMed ID: 21422956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
    Daniel GW; Malone DC
    J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
    Jung K; McBean AM; Kim JA
    J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population.
    Chinthammit C; Armstrong EP; Boesen K; Martin R; Taylor AM; Warholak T
    J Manag Care Spec Pharm; 2015 May; 21(5):381-9. PubMed ID: 25942999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL; Ruscin JM
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with adverse drug events among older adults in emergency department.
    Chen YC; Fan JS; Chen MH; Hsu TF; Huang HH; Cheng KW; Yen DH; Huang CI; Chen LK; Yang CC
    Eur J Intern Med; 2014 Jan; 25(1):49-55. PubMed ID: 24200546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare program; identification of backward compatible version of adopted standard for e-prescribing and the Medicare prescription drug program (NCPDP SCRIPT 10.6). Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Jul; 75(126):38026-30. PubMed ID: 20608287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
    Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
    J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug events identified by triggers at a teaching hospital in Brazil.
    Giordani F; Rozenfeld S; Martins M
    BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.